Drug Type Biological products |
Synonyms |
Target |
Action inhibitors |
Mechanism Tubulin inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Phase 1 | United States | - | |
Lung Cancer | Phase 1 | United States | - | |
Ovarian Epithelial Carcinoma | Phase 1 | United States | - | |
Pancreatic Cancer | Phase 1 | United States | - | |
Prostatic Cancer | Phase 1 | United States | - | |
Fibrosis | Preclinical | Spain | 01 Apr 2025 | |
Sarcoma | Preclinical | Spain | 01 Apr 2025 | |
Solid tumor | Preclinical | Spain | 01 Apr 2025 |